Clinical trial
Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and…
NCT00113334 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00113334 |
|---|---|
| Title | Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer |
| Official title | A Phase 1b/2 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | ABT-510 |
| Enrollment | 6 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Jun 8, 2005 |
| Last update posted | Aug 7, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: